Table 1.
Clinicopathological characteristics of 115 patients undergoing DP
| Variable | All patients (n = 115) |
|---|---|
| Gender, n (%) | |
| Male | 34 (29.6) |
| Female | 81 (70.4) |
| Age (y), median (IQR) | 53.0 (45.5–62.0) |
| BMI (kg/m2), n (%) | |
| < 25 | 63 (54.8) |
| ≥ 25 | 52 (45.2) |
| Hypertension, n (%) | |
| No | 96 (83.5) |
| Yes | 19 (16.5) |
| Diabetes, n (%) | |
| No | 95 (82.6) |
| Yes | 20 (17.4) |
| Smoking, n (%) | |
| No | 93 (80.9) |
| Yes | 22 (19.1) |
| Alcohol abuse, n (%) | |
| No | 99 (86.1) |
| Yes | 16 (13.9) |
| Hemoglobin (g/L), median (IQR) | 131 (122–140) |
| Prealbumin (g/L), median (IQR) | 210 (184–251) |
| Albumin (g/L), n (%) | |
| ≥ 35 | 90 (78.3) |
| < 35 | 25 (21.7) |
| CA199 (KU/L), median (IQR) | 16.2 (5.80–76.8) |
| Operation time (min), median (IQR) | 287 (231–352) |
| Blood loss (mL), median (IQR) | 300 (200–550) |
| Surgical approach, n (%) | |
| Laparoscopic | 16 (13.9) |
| Open | 99 (86.1) |
| Ligation of main pancreatic duct, n (%) | |
| No | 54 (47.0) |
| Yes | 61 (53.0) |
| Pancreatic stump treatment, n (%) | |
| Endo GIA stapler | 30 (26.1) |
| Suture | 85 (73.9) |
| Pathology, n (%) | |
| PDAC | 36 (31.3) |
| Cystic | 45 (39.13) |
| Pancreatitis | 10 (8.7) |
| Neuroendocrine | 13 (11.3) |
| SPTP | 9 (7.83) |
| Others | 2 (1.74) |
| Pancreas thickness (mm), median (IQR) | 17.2 (15.3–20.2) |
| Pancreas texture, n (%) | |
| Hard | 69 (60.0) |
| Soft | 46 (40.0) |
| Splenectomy, n (%) | |
| No | 56 (48.7) |
| Yes | 59 (51.3) |
| CR-POPF, n (%) | |
| No | 77 (67.0) |
| Yes | 38 (33.0) |
BMI body mass index; IQR interquartile range; CA199 cancerantigen199; PDAC pancreatic ductal adenocarcinoma; SPTP solid pseudopapillary tumor of the pancreas